Short Interest in HeartSciences Inc. (NASDAQ:HSCS) Rises By 115.9%

HeartSciences Inc. (NASDAQ:HSCS) saw a significant growth in short interest in the month of June. As of June 30th, there was short interest totaling 123,640 shares, a growth of 115.9% from the June 15th total of 57,278 shares. Based on an average daily volume of 13,681,823 shares, the days-to-cover ratio is presently 0.0 days. Currently, 4.1% of the shares of the company are short sold.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the company. Ascendiant Capital Markets reduced their price objective on HeartSciences from $9.00 to $8.00 and set a “buy” rating for the company in a research report on Tuesday, March 24th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of HeartSciences in a research note on Wednesday, June 24th. One investment analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $8.00.

Institutional Investors Weigh In On HeartSciences

An institutional investor recently bought a new stake in HeartSciences stock. Geode Capital Management LLC purchased a new stake in shares of HeartSciences Inc. (NASDAQ:HSCS) in the second quarter, according to its most recent disclosure with the SEC. The firm purchased 11,599 shares of the company’s stock, valued at approximately $43,000. Geode Capital Management LLC owned approximately 0.51% of HeartSciences as of its most recent filing with the SEC. 17.24% of the stock is owned by hedge funds and other institutional investors.

HeartSciences Price Performance

HeartSciences stock traded up $0.18 during trading hours on Thursday, hitting $2.74. 103,773 shares of the company traded hands, compared to its average volume of 1,075,156. The firm has a market cap of $8.73 million, a P/E ratio of -0.55 and a beta of 1.78. The company has a quick ratio of 1.04, a current ratio of 1.19 and a debt-to-equity ratio of 0.16. The firm’s 50-day simple moving average is $2.20 and its two-hundred day simple moving average is $2.52. HeartSciences has a 1-year low of $1.63 and a 1-year high of $4.30.

HeartSciences Company Profile

HeartSciences, Inc (NASDAQ: HSCS) is a medical device company focused on the development and commercialization of advanced, non‐invasive cardiac diagnostic technologies. The company’s flagship product, MyoVista, is a high‐fidelity electrocardiograph (ECG) designed to detect subtle changes in cardiac function that may indicate myocardial ischemia or left ventricular dysfunction. By leveraging high‐frequency wavelet analysis within the QRS complex, MyoVista provides clinicians with enhanced visualization and analytical capabilities that extend beyond those of standard ECG systems.

HeartSciences supports the MyoVista system with an integrated software suite that automates data analysis and report generation, facilitating seamless integration into existing clinical workflows.